Dailypharm Live Search Close

PVA exemptions expanded to drugs below KRW 3 billion

By Lee, Tak-Sun | translator Kim, Jung-Ju

24.04.16 08:03:32

°¡³ª´Ù¶ó 0
The formula for negotiated prices will be differentially calculated based on the claim amounts of drugs

A one-time refund contract is also possible¡¦To be implemented on May 1st



Effective this year, the price-volume agreement (PVA) criteria will be expanded to provide an exemption to products with a claim amount below KRW 3 billion. This amount represents an increase from the previous criteria, which was below KRW 2 billion.

Also, any product that has undergone more than two price reductions in the last five years will receive a 30% cuts. The reduction rate will be differentially applied depending on the claimed amount.

Since April 15th, the National Health Insurance Service (NHIS) has been collecting opinions regarding the partial revision of the 'Detailed Matters regarding PVA negotiation¡¯s operational guidelines.' The revised program will be implement

Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)